Genetic Determinants of Opioids Analgesia
NCT00226564 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2008-10-29
Summary
The response to opioids varies greatly among individuals. Some of these variability is accounted for by genetic factors.
The present study was designed to evaluate the possibility that genetic polymorphism in the gene encoding for mu opioid receptor may explain variability in the response to alfentanil during lithotripsy.
Conditions
- Nephrolithiasis
Interventions
- DRUG
-
Alfentanil
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Principal Investigators
-
Yoseph Caraco, MD · Hadassah Medical Organization
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-08-31
Countries
- Israel
Study Locations
More Related Trials
-
Morphine Versus Morphine-promethazine Combination for Acute Low Back Pain Relief in the Adult Emergency Department
NCT01129934 ·Status: UNKNOWN ·Phase: PHASE4
-
pRedicting the Long-term rEsponse of High Frequency sPinal cOrd sTimulation in Patients With Failed Back Surgery Syndrome.
NCT04500691 ·Status: COMPLETED
-
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Acute Pain Trial)
NCT05966129 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery
NCT00390039 ·Status: COMPLETED ·Phase: PHASE3
-
Opioid-sparing Effect of Intravenous Ibuprofen
NCT03016650 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain
NCT00226421 ·Status: COMPLETED ·Phase: PHASE3
-
Developing a Method to Objectively Measure Opioid Analgesia
NCT03605966 ·Status: ACTIVE_NOT_RECRUITING
-
Endogenous Opioid Response to Injections
NCT06666621 ·Status: RECRUITING ·Phase: PHASE4
-
A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Chronic Pain Trial)
NCT05966142 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Fentanyl Following Intravenous and Oral Routes of Administration in Healthy Volunteers
NCT00714558 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Abuse Potential of Cebranopadol in Humans
NCT05256108 ·Status: COMPLETED ·Phase: PHASE1
-
Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function
NCT03616639 ·Status: TERMINATED ·Phase: PHASE4
-
Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain
NCT01327326 ·Status: WITHDRAWN ·Phase: NA
-
Pain Outcomes of Non-opioid vs. Opioid Analgesia for Kidney Stone Surgery.
NCT03584373 ·Status: COMPLETED ·Phase: PHASE3
-
Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation
NCT00349401 ·Status: WITHDRAWN ·Phase: PHASE2
-
Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms
NCT05142267 ·Status: RECRUITING ·Phase: NA
-
Side Effects of a Single Shot Intrathecal Morphine in Clinical Practice, a Retrospective Analysis
NCT07238179 ·Status: ACTIVE_NOT_RECRUITING
-
The Relationships Between the Noradrenergic, Opioid and Pain System
NCT01851486 ·Status: WITHDRAWN ·Phase: NA
-
Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation).
NCT01750060 ·Status: COMPLETED ·Phase: PHASE1
-
The Optimization of Procedural Pain Control in Intensive Care Unit (ICU) Patients
NCT00558090 ·Status: COMPLETED ·Phase: NA
-
Visceral Pain From the Upper Urinary Tract - a Trial on the Effect of Morphine and Oxycodone in Patients Undergoing PCNL
NCT00784472 ·Status: COMPLETED ·Phase: PHASE3
-
OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models
NCT00271973 ·Status: COMPLETED ·Phase: PHASE4
-
Apomorphine Effects on Experimental Pain
NCT01744964 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users
NCT01825447 ·Status: COMPLETED ·Phase: PHASE1
-
RM1 Project 1 - tAN Naloxone
NCT05490134 ·Status: RECRUITING ·Phase: EARLY_PHASE1